BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Herrera S, Colmenero J, Pascal M, Escobedo M, Castel MA, Sole-González E, Palou E, Egri N, Ruiz P, Mosquera M, Moreno A, Juan M, Vilella A, Soriano A, Farrero M, Bodro M. Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients. Am J Transplant 2021. [PMID: 34291552 DOI: 10.1111/ajt.16768] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Crespo M, Barrilado-Jackson A, Padilla E, Eguía J, Echeverria-Esnal D, Cao H, Faura A, Folgueiras M, Solà-Porta E, Pascual S, Barbosa F, Hurtado S, Ribera L, Río-No L, Pérez-Sáez MJ, Redondo-Pachón D, Pascual J; Mariscovid Research Group. Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring. Am J Transplant 2021. [PMID: 34551187 DOI: 10.1111/ajt.16854] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ferreira VH, Marinelli T, Ierullo M, Ku T, Hall VG, Majchrzak-Kita B, Kulasingam V, Humar A, Kumar D. SARS-CoV-2 infection induces greater T-cell responses compared to vaccination in solid organ transplant recipients. J Infect Dis 2021:jiab542. [PMID: 34739078 DOI: 10.1093/infdis/jiab542] [Reference Citation Analysis]
3 Russo G, Lai Q, Poli L, Perrone MP, Gaeta A, Rossi M, Mastroianni CM, Garofalo M, Pretagostini R. SARS-COV-2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications. Clin Transplant 2021;:e14495. [PMID: 34569101 DOI: 10.1111/ctr.14495] [Reference Citation Analysis]
4 Windpessl M, Heine GH, Becker SL, Scheuer AL, Sester M, Kronbichler A. [The impact of immunosuppression and chronic kidney disease on immunogenicity of COVID-19 vaccines]. Dtsch Med Wochenschr 2021;146:1277-82. [PMID: 34553353 DOI: 10.1055/a-1550-7288] [Reference Citation Analysis]
5 Giannella M, Righi E, Pascale R, Rinaldi M, Caroccia N, Gamberini C, Palacios-baena ZR, Caponcello G, Morelli MC, Tamè M, Busutti M, Comai G, Potena L, Salvaterra E, Feltrin G, Cillo U, Gerosa G, Cananzi M, Piano S, Benetti E, Burra P, Loy M, Furian L, Zaza G, Onorati F, Carraro A, Gastaldon F, Nordio M, Kumar-singh S, Abedini M, Boffetta P, Rodríguez-baño J, Lazzarotto T, Viale P, Tacconelli E; on behalf of The ORCHESTRA Study Group Workpackage. Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort. Microorganisms 2022;10:1021. [DOI: 10.3390/microorganisms10051021] [Reference Citation Analysis]
6 Du L, Yang Y, Zhang X, Li F. Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies. Nanoscale 2022. [PMID: 35018939 DOI: 10.1039/d1nr03831a] [Reference Citation Analysis]
7 Abravanel F, Marion O, Del Bello A, Beunon T, Romieu-mourez R, Couat C, Pucelle M, Staes L, Guitard J, Esposito L, Faguer S, Kamar N, Izopet J. Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine. Vaccines 2022;10:354. [DOI: 10.3390/vaccines10030354] [Reference Citation Analysis]
8 Nimmo A, Gardiner D, Ushiro-lumb I, Ravanan R, Forsythe JLR. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004151] [Reference Citation Analysis]
9 Cuadrado A, Del Barrio M, Fortea JI, Amigo L, San Segundo D, Rodriguez-Cundin MP, Rebollo MH, Fernandez-Santiago R, Castillo F, Achalandabaso M, Echeverri J, Anderson EJ, Rodríguez-Sanjuan JC, López-Hoyos M, Crespo J, Fábrega E. Antibody response to the messenger RNA-1273 vaccine (Moderna) in liver transplant recipients. Hepatol Commun 2022. [PMID: 35344281 DOI: 10.1002/hep4.1937] [Reference Citation Analysis]
10 Egri N, Juan M. Immunology in COVID-19; more than diagnosis of infection or the basis of vaccination. Med Clin (Barc) 2021:S0025-7753(21)00637-0. [PMID: 34872770 DOI: 10.1016/j.medcli.2021.11.001] [Reference Citation Analysis]
11 Galmiche S, Luong Nguyen LB, Tartour E, de Lamballerie X, Wittkop L, Loubet P, Launay O. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clin Microbiol Infect 2021:S1198-743X(21)00566-8. [PMID: 35020589 DOI: 10.1016/j.cmi.2021.09.036] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Toniutto P, Falleti E, Cmet S, Cussigh A, Veneto L, Bitetto D, Fornasiere E, Fumolo E, Fabris C, Sartor A, Peressutti R, Curcio F, Regattin L, Grillone L. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.02.015] [Reference Citation Analysis]
13 Danziger-Isakov L, Sester M. Unpacking the COVID-19 vaccine responses: Do we have what we need for a successful trip? Am J Transplant 2021;21:3827-8. [PMID: 34510723 DOI: 10.1111/ajt.16833] [Reference Citation Analysis]
14 Peluso MJ, Donatelli J, Henrich TJ. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions. Transl Res 2021:S1931-5244(21)00269-3. [PMID: 34780969 DOI: 10.1016/j.trsl.2021.11.006] [Reference Citation Analysis]
15 Aslam S, Ison MG. SARS-CoV-2 vaccination in heart transplantation: What we do and do not know. J Heart Lung Transplant 2021:S1053-2498(21)02573-0. [PMID: 34876356 DOI: 10.1016/j.healun.2021.10.017] [Reference Citation Analysis]
16 Giannella M, Pierrotti LC, Helanterä I, Manuel O. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know. Transpl Int 2021;34:1776-88. [PMID: 34450686 DOI: 10.1111/tri.14029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 San Segundo D, Comins-Boo A, Lamadrid-Perojo P, Irure-Ventura J, Castillo-Otí JM, Wallman R, Calvo-Montes J, Méndez-Legaza JM, Baamonde-Calzada C, Sánchez-Molina I, Lecue-Martínez M, Ventisca-Pérez S, Batlle-López A, Hoyos ML. COVID-19 mRNA Based Vaccine Immune-Response Assessment in Nursing Home Residents for Public Health Decision. Vaccines (Basel) 2021;9:1429. [PMID: 34960173 DOI: 10.3390/vaccines9121429] [Reference Citation Analysis]
18 Fernández-Ruiz M, Almendro-Vázquez P, Carretero O, Ruiz-Merlo T, Laguna-Goya R, San Juan R, López-Medrano F, García-Ríos E, Más V, Moreno-Batenero M, Loinaz C, Andrés A, Pérez-Romero P, Paz-Artal E, Aguado JM. Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients. Transplant Direct 2021;7:e794. [PMID: 34805496 DOI: 10.1097/TXD.0000000000001246] [Reference Citation Analysis]
19 Hoffman TW, Meek B, Rijkers GT, van Kessel DA. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients. Transpl Immunol 2022;72:101599. [PMID: 35390480 DOI: 10.1016/j.trim.2022.101599] [Reference Citation Analysis]
20 Lindemann M, Klisanin V, Thümmler L, Fisenkci N, Tsachakis-Mück N, Ditschkowski M, Schwarzkopf S, Klump H, Reinhardt HC, Horn PA, Koldehoff M. Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients. Vaccines (Basel) 2021;9:1075. [PMID: 34696183 DOI: 10.3390/vaccines9101075] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]